Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1

  title={Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1},
  author={David P. Fidler},
  journal={PLoS Medicine},
  • D. Fidler
  • Published 1 May 2010
  • Medicine, Political Science
  • PLoS Medicine
As part of the PLoS Medicine series on Global Health Diplomacy, David Fidler provides a case study of the difficult negotiations to increase equitable access to vaccines for highly pathogenic avian influenza A (H5N1) and pandemic 2009 influenza A (H1N1). 

WHO’s Pandemic Influenza Preparedness Framework: A Milestone in Global Governance for Health

The PIP Framework is a landmark for global governance for health because it is the first international agreement facilitating influenza virus and benefit sharing, but it is not legally binding, avoids intellectual property issues that complicated the negotiations, does not include commitments from developed countries to donate portions of influenza vaccines they purchase, and faces implementation challenges in an increasingly difficult global health environment.

Virus sharing, genetic sequencing, and global health security

The changes that need to be made to address the growing likelihood that genetic sequence data might be shared instead of physical virus samples, as well as the need to expand the PIP framework’s scope and to improve its fairness are examined.

Multivalue ethical framework for fair global allocation of a COVID-19 vaccine

This piece analyses four allocation paradigms: ability to develop or purchase; reciprocity; ability to implement; and distributive justice, and synthesises their ethical considerations to develop an allocation model to fit the COVID-19 pandemic.

Developing Nations and Disadvantaged Populations: How the 2009 H1N1 Influenza Pandemic Exacerbated Disparities and Inequities

This paper will investigate how socioeconomic and political disparities encountered before and during the pandemic caused differential health, societal, political, and economic outcomes and offer recommendations that can be used by policymakers to mitigate impacts faced by disadvantaged populations and to improve global health security.

The Equitable Distribution of COVID-19 Therapeutics and Vaccines.

Here is a proposal for global cooperation to ensure equitable distribution of vaccines and therapies for COViD-19, with a common global interest.

Vaccinate before the next pandemic?

Pre-pandemic immunization with a cocktail of likely strains could be a cheap, practical and equitable way to protect people against influenza, says Novartis' Klaus Stohr.

Equitable and Effective Distribution of the COVID-19 Vaccines – A Scientific and Moral Obligation

As the COVID-19 vaccines are distributed, pharmaceutical companies should share their technology to increase supply and reduce prices, governments should prioritize equitable distribution to the most at-risk in all nations and low-income countries should bolster their logistical capacity in preparation for mass vaccination campaigns.

Biopiracy and Vaccines: Indonesia and the World Health Organization's New Pandemic Influenza Plan

Viral samples of avian influenza are essential to preparing pre-pandemic vaccines. In 2007, the conflicting interests of the developed and developing nations led Indonesia to briefly stop sharing

An intersectional human rights approach to prioritising access to COVID-19 vaccines

It is argued that the practical implementation of human rights law requires broader consideration of intersectional needs in society and the disproportionate impact that COVID-19 is having on population groups with pre-existing social and medical vulnerabilities.



Influenza Virus Samples, International Law, and Global Health Diplomacy

  • D. Fidler
  • Political Science
    Emerging infectious diseases
  • 2008
An incident that involved withholding avian influenza virus samples illustrates the importance and limitations of international law in global health diplomacy.

Poverty, wealth, and access to pandemic influenza vaccines.

The prospects for developing an effective vaccine to prevent infection with the current H1N1 virus are excellent and a set of principles to guide global allocation of a pandemic vaccine is proposed.

Pandemic influenza vaccine policy--considering the early evidence.

  • K. Neuzil
  • Medicine, Political Science
    The New England journal of medicine
  • 2009
Preliminary data on the immunogenicity of the influenza A (H1N1) 2009 monovalent vaccine are described, as governments, public health officials, and other stakeholders respond to the first vaccine dose.


[The next pandemic?].

  • L. Garrett
  • Political Science
    Salud publica de Mexico
  • 2006
If the relentlessly evolving virus becomes capable of human-to-human transmission, develops a power of contagion typical of human influenzas, and main tains its extraordinary virulence, humanity could well face a pandemic.

Global strategy and plan of action on public health, innovation and intellectual property

Implementation of the global strategy and plan of action has been harmonized with implementation of the WHO strategy on research for health, and particularly the work on the Global Observatory on Health Research and Development (hereinafter the “Observatory”).

Law of the Sea

NOTE Symbols of United Nations documents are composed of capital letterscombinded with figures. Mention of such a symbol indicates a reference to a United Nations document. iii Foreword The 1982

Principles of Public International Law

Abbreviations Table of Cases Glossary PART I: PRELIMINARY TOPICS I. Sources of the Law II: The Relation of Municipal and International Law PART II: PERSONALITY AND RECOGNITION III. Subjects of the

Nation is facing vaccine shortage for seasonal flu

  • N. Y. Times, 4 November. Available: http://www.nytimes. com/2009/11/05/health/05flu.html. Accessed
  • 2009